• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer

www.myfederalretirement.com

Financial Planning Resources for Federal & Postal Employees

  • FREE Newsletter
  • Pay & COLAs
  • Thrift Savings
  • Insurance
  • FERS / CSRS
  • Find A Professional
  • Workshops
  • Podcast

GLP-1 Coverage in FEHB for 2027: New Therapy Requirements and $50 Medicare Option

November 16, 2026 My Federal Retirement


Try the 2027 FEHB Plan Cost Explorer:
Compare Plans at Your ZIP Code


Open Season for the 2027 plan year runs from November 9 through December 14, 2026, and anyone taking a glucagon-like peptide-1 (GLP-1) medication for weight loss has more to check than premiums. The Office of Personnel Management (OPM) is tightening the rules for anti-obesity medication coverage in the Federal Employees Health Benefits (FEHB) Program, plan cost sharing for these drugs varies widely, and Medicare retirees have a separate $50 option that depends on which type of drug coverage they hold.

What OPM requires for 2027

According to OPM’s Open Season highlights, every FEHB and Postal Service Health Benefits (PSHB) plan must continue to cover at least one GLP-1 drug for obesity, along with at least two anti-obesity medications taken by mouth. Each plan still chooses which brands go on its formulary, so the GLP-1 a doctor prescribes may not be the one covered.

The new requirement for 2027 is proof of participation in a structured, evidence-based intensive behavioral therapy (IBT) program, both before treatment starts and while it continues. Plans are expected to cover between 12 and 22 IBT sessions per year, depending on progress. Carriers design their own programs, so someone already on treatment should ask how earlier sessions are credited and what documentation the plan will want.

Why the rules are changing

The OPM Office of Inspector General’s data brief reviewed two large carriers, together covering 69% of FEHB members, and found yearly GLP-1 spending climbing from roughly $393 million in 2019 to $2.6 billion in 2024, with the drugs growing from 4% to 18% of pharmacy spending. Almost 385,000 members received a GLP-1 for the first time in 2023 and 2024, compared with roughly 200,000 over the four years from 2019 to 2022. The counts include diabetes prescriptions, not only weight-loss use.

Prescription drug costs, with GLP-1s singled out, are among the reasons OPM gives for the 2027 premium increase. The average enrollee share for FEHB is rising 10.9%.

Why GLP-1 costs vary by FEHB plan

Plans decide which GLP-1 drugs are covered, which tier they sit in, and whether the member pays a flat copayment or a percentage of the plan’s price. The “Changes for 2027” section of each plan brochure shows any shift. The higher a drug’s price, the more a switch from a flat copayment to coinsurance changes the bill. The figures below are round numbers chosen to show the arithmetic, not prices from any plan or pharmacy.


Ad

Turn 65, and your FEHB decisions get harder — not easier

Whether to keep FEHB, add Medicare Part B, or do both isn’t a simple yes-or-no — and the wrong call can mean paying for coverage you don’t need. This workshop lays it out, plus everything else you need to know. Get the details at a free FedImpact Workshop near you.


Illustrative monthly drug price Flat $90 copayment 45% coinsurance Medicare GLP-1 Bridge
$500 $90 $225 $50
$800 $90 $360 $50
$1,200 $90 $540 $50

The Bridge column applies only to people who qualify and are not already covered for a GLP-1 through Part D, as explained below. Real totals also depend on the plan’s annual out-of-pocket limit, any discounts, and how many days each fill covers.

Weight-loss GLP-1 coverage looks different from one Federal Employees Health Benefits (FEHB) plan to the next in 2027. The table below summarizes what the 2027 brochures of seven nationwide plans say about glucagon-like peptide-1 (GLP-1) medications prescribed for weight loss, with the brochure section to check for each. It reflects brochure text read on November 16, 2026, and it is not a price list, because the dollar amount depends on the price the plan uses for each drug.

2027 weight-loss GLP-1 terms in seven nationwide FEHB plans

What the brochures show

Five of the seven plans apply 50% coinsurance to weight-loss GLP-1s under at least one option: APWU, FSBP, GEHA High Option, MHBP, and SAMBA. Compass Rose places these drugs in Tier 3 with a different charge, and the Blue Cross plan leaves the cost to the formulary tier. Nearly every plan also ties coverage to a weight-management or behavioral program, which fits the intensive behavioral therapy requirement OPM describes for 2027.

Coinsurance means the cost rises with the drug’s price. A 50% share of a high monthly price can exceed a flat copayment several times over, so the right comparison is each plan’s yearly premium plus the expected cost of the specific drug and dose.

What is not covered here

  • GEHA Standard Option and Compass Rose Standard Option, for the reasons noted in the table.
  • Blue Cross plans where the cost depends on the drug list, which would need the specific drug’s tier.
  • Other nationwide plans, including FEP Blue Focus, GEHA’s high deductible and indemnity plans, and the regional plans that appear only when a state is selected, along with Postal Service Health Benefits plans.
  • Medicare drug plan terms. FSBP’s and MHBP’s brochures describe group Part D plans, but the sections read did not state how those plans treat weight-loss GLP-1s, so retirees should ask the carrier. See how FEHB and Medicare work together.

How to use the table

  • Open the brochure for the current plan and read the section listed in the last column, plus the “Changes for 2027” list near the front.
  • Look up the exact drug and dose on the carrier’s 2027 drug list and ask for a written cost estimate.
  • Ask the carrier what program documentation is needed and whether earlier participation counts.
  • Compare plans with OPM’s plan comparison tool before the Open Season deadline on December 14.
Plan Cost share for weight-loss GLP-1s Program and approval requirements Where to check
American Postal Workers Union (APWU) Health Plan, High Option and Consumer Driven Health Plan (CDHP) 50% coinsurance at network retail pharmacies for 30-day and 90-day supplies. The CDHP lists non-network retail as not covered. Prior authorization required. Participation in the Teladoc Health Comprehensive Weight Care program is required to obtain the medication. Section 5(f), page 71 (High Option) and page 121 (CDHP); Section 5(h)
Blue Cross and Blue Shield Service Benefit Plan, Standard and Basic Options No separate obesity-drug cost share. Cost depends on the drug’s formulary tier. Standard Option: 30% coinsurance for Tier 2, 50% for Tier 3. Basic Option: 35% for Tier 2 (up to $175 per 30-day fill), 60% for Tier 3. The brochure text read does not say which tier a given GLP-1 occupies. Drugs prescribed to treat obesity require prior approval. The sections read did not describe a program requirement. Section 5(f); the plan’s 2027 drug list
Compass Rose Health Plan, High and Standard Options The brochure classifies prescription anti-obesity medications as Tier 3 drugs. The High Option Tier 3 charge at retail is 40% of the plan cost or $75, whichever is greater, and 40% or $150 at home delivery. The Standard Option Tier 3 cost is unclear in the brochure text, so it should be confirmed with the plan. Active participation in the plan’s Weight Management and Lifestyle Program is required for certain anti-obesity medications. The prior authorization rules in Section 5(f) may also apply. Section 2; Section 5(f), “Covered medications and supplies”
Foreign Service Benefit Plan (FSBP), open only to specific groups 50% coinsurance with no deductible at in-network pharmacies, for up to a 30-day retail or 90-day home delivery supply. Out-of-network retail pharmacies within the 50 states: 100% of the cost. Participation in the EncircleRx program is mandatory. The brochure calls for four documented weigh-ins and four Teladoc Health app engagements per month. Weight loss medications may require prior authorization. Section 2; Section 5(f), page 91
Government Employees Health Association (GEHA) Benefit Plan, High Option 50% coinsurance at network retail, non-network retail, and mail service pharmacies. The tiered cost sharing no longer applies to these drugs. Prior authorization required. Participation in the plan’s weight management program is required to obtain anti-obesity medications. Section 2, “Changes to High Option Only”; Section 5(f)
GEHA Benefit Plan, Standard Option Section 2 lists no obesity-drug cost-share change for this option, and the brochure text does not give a separate figure. It should be confirmed with GEHA. The program participation requirement in Section 2 applies to both options. Prior authorization required. Section 2; Section 5(f)
Mail Handlers Benefit Plan (MHBP), Standard Option A separate tier for anti-obesity medications: 50% of the plan’s allowance for up to a 30-day supply at a network pharmacy or up to a 90-day supply by mail order, with no deductible and no per-prescription cap. Enrollment in the CVS Weight Management Program is required before coverage begins, and members must stay actively engaged. The program is free. Certain drugs require prior authorization, so the specific medication should be checked. Section 2, page 17; Section 5(f), page 83
SAMBA Health Benefit Plan, High and Standard Options Covered GLP-1 weight loss medications are covered at 50% of the plan allowance under both options. Before 2027 they were paid at the same copayment or coinsurance as other covered prescriptions. Existing prior authorization requirements and participation in the plan’s lifestyle management program remain in effect. Section 2, page 14; Section 5(f), page 81

The above table summary is general information, not advice for an individual situation. It reflects the text of OPM-published 2027 brochures as read on November 16, 2026, and plan terms can change, be corrected, and information could have been inadvertently omitted.  Confirm the cost of a specific drug in the official brochure and with the FEHB carrier before making a coverage decision.

Is FEHB drug coverage the same as Medicare Part D?

No. The prescription benefit built into an FEHB plan is separate from Medicare Part D. The two connect through the Employer Group Waiver Plan (EGWP), a Part D plan that many FEHB carriers offer to annuitants with Medicare. At least one 2027 brochure says its group Part D plan is open only to annuitants who are eligible for Part D, that those members are enrolled automatically, and that they can opt out at any time. Active employees cannot enroll in it.

FEHB prescription drug coverage is generally considered creditable coverage for Medicare Part D, meaning it is expected to pay, on average, at least as much as standard Medicare drug coverage. Retirees can generally delay Part D enrollment without a late enrollment penalty while maintaining creditable FEHB coverage. Timing still matters if that coverage ends, because a gap of 63 days or longer without creditable coverage can raise the Part D premium by at least 1% for each month of the gap. Medicare.gov explains creditable coverage in more detail.

For this topic, there is a trade-off. Relying on creditable FEHB coverage and skipping Part D, or opting out of a carrier’s group Part D plan, means the $50 Bridge is out of reach, because the Bridge requires Part D enrollment. Whether a carrier’s Medicare drug plan already covers weight-loss GLP-1s also varies, so the carrier should be asked directly before assuming the Bridge is needed or available.

The $50 Medicare GLP-1 Bridge

The Medicare GLP-1 Bridge is a temporary program run by the Centers for Medicare & Medicaid Services (CMS). It runs from July 1, 2026 through December 31, 2027, and it works outside the Part D benefit itself. Medicare.gov lists the plan types that qualify: stand-alone drug plans, Medicare Advantage plans with drug coverage, Special Needs Plans, and employer or union group waiver plans. An FEHB carrier’s group Part D plan is a group waiver plan, so it counts.

Situation Can use the $50 Bridge?
Enrolled in Part D through the FEHB carrier’s group plan Potentially, if all Bridge eligibility requirements are met
Enrolled in a stand-alone Part D plan Potentially, if all Bridge eligibility requirements are met
Has Medicare and FEHB but no Part D No, Part D enrollment is required
Has FEHB only, not enrolled in Medicare No, the program is for Medicare Part D enrollees
Already gets a GLP-1 covered through a Part D plan No, the Bridge is not available for that covered treatment

Qualifying is also a medical question. Medicare.gov lists these requirements at the start of therapy, for adults 18 and older:

  • A body mass index (BMI) of 35 or higher, or
  • A BMI of 30 or higher with heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease stage 3a or higher, or
  • A BMI of 27 or higher with prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease

People with type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease are not eligible because Part D plans are expected to cover GLP-1 drugs for those conditions. The program covers Wegovy (injection or tablet), Foundayo tablets, and the Zepbound KwikPen. Single-dose Zepbound pens and vials are not included.

The doctor, not the FEHB plan, sends the prescription and, when requested, completes the prior authorization, certifying that the drug is part of a diet and exercise program. Approval stays valid through December 31, 2027, unless the person switches to a different GLP-1.

How the $50 compares with the plan price

The $50 copayment is flat for a 28-day or 30-day supply, but it carries limits. It does not count toward the Part D deductible or the annual Part D out-of-pocket limit, it does not appear on the Part D Explanation of Benefits, and Extra Help cannot lower it. The copayment also cannot be spread across multiple months through the Medicare Prescription Payment Plan. Whether it counts toward an FEHB plan’s own out-of-pocket maximum is a question for the carrier. CMS says the program is scheduled to end December 31, 2027, and nothing in CMS’s materials guarantees coverage afterward.

For someone whose Part D plan already covers their GLP-1 medication, the plan’s regular cost-sharing rules generally apply, and the Bridge is not available for that covered treatment. For someone whose prescribed drug is not covered through Part D, the Bridge may provide a lower-cost option if all eligibility requirements are met. The answer depends on the drug, the person’s medical circumstances, and their existing coverage.

What to do before December 14

  • Read the “Changes for 2027” section of the current plan’s brochure, and look up the exact GLP-1 drug and dose on the carrier’s prescription drug tool.
  • Ask the carrier what documentation of intensive behavioral therapy is needed and whether existing participation counts.
  • Use OPM’s plan comparison tool to compare plans. Compare each plan’s yearly premium plus what the drug would cost, not the premium alone. The FEHB Open Season checklist lists the other steps.
  • For retirees with Medicare, confirm whether Part D is in place, whether the carrier enrolled them in its group plan automatically, and whether that plan covers weight-loss GLP-1s.
  • Talk with the prescriber before any change, since a coverage gap can interrupt treatment.

Official sources

  • OPM: Federal Benefits Open Season Highlights, 2027 Plan Year (PDF)
  • OPM: FEHB plan comparison tool
  • OPM Office of Inspector General: FEHB GLP-1 spending data brief (PDF)
  • Medicare.gov: Weight loss drugs (Medicare GLP-1 Bridge)
  • Medicare.gov: Creditable coverage
  • CMS: Medicare GLP-1 Bridge

This article is general information, not advice for an individual situation. Plan benefits, drug prices, and program rules can change, so confirm details in the official plan brochure, with the FEHB carrier, or with Medicare at 1-800-MEDICARE before making coverage decisions.

Related:

  • The Financial Planning Pep Talk for Federal Employees
  • 2027 FEHB Plan Changes: Nine Plans Leaving and UnitedHealthcare’s HSA Plan Ending in 12 States

Primary Sidebar

Recent Must-Reads

2027 Thrift Savings Plan Maximum Contribution Limits

Nvidia and the TSP C Fund: How Much Can One Stock Matter?

Footer

About Us
Contact Us
Editorial Standards
Advertise

Free Email Newsletter
Facebook
Twitter

Terms of Service
Privacy Policy
Cookies Policy

My Federal Retirement is not affiliated with the U.S. Federal Government.
Copyright © 2007-2026 My Federal Retirement. All Rights Reserved. Reproduction without permission prohibited.